Stay updated on UBX0101 Safety & Efficacy in Knee Osteoarthritis Clinical Trial

Sign up to get notified when there's something new on the UBX0101 Safety & Efficacy in Knee Osteoarthritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the UBX0101 Safety & Efficacy in Knee Osteoarthritis Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-26T11:01:00.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page has undergone a version update from v2.14.4 to v2.15.0, indicating a significant revision. Additionally, a specific reference to the Investigators Study Director role at UNITY Biotechnology has been removed.
    Difference
    0.5%
    Check dated 2025-04-19T04:12:58.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The web page now includes detailed results from a clinical trial comparing the effects of UBX0101 to a placebo on pain and physical disability scores over 12 weeks, as measured by the WOMAC-A and WOMAC-C scales.
    Difference
    15%
    Check dated 2025-04-11T22:21:29.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.14.4, with significant deletions related to the WOMAC-A and WOMAC-C scores in a clinical study, including details about the analysis population and score assessments.
    Difference
    13%
    Check dated 2025-04-04T20:05:13.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-03-27T14:44:26.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page now includes detailed results from a clinical study comparing the WOMAC-A and WOMAC-C scores in patients receiving UBX0101 versus placebo, highlighting significant changes in pain and physical disability over a 12-week period. Additionally, there is a note about missing data for some subjects in the analysis.
    Difference
    16%
    Check dated 2025-02-26T20:01:21.000Z thumbnail image

Stay in the know with updates to UBX0101 Safety & Efficacy in Knee Osteoarthritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the UBX0101 Safety & Efficacy in Knee Osteoarthritis Clinical Trial page.